Miguel Vargas-Lagunas, MD
Internal Medicine · North Las Vegas, NVNPI 1356551873
Payments from drug & device makers
Across 49 payments — averaging $10.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$312
- Redhill Biopharma Inc.$46
- Genentech USA, Inc.$23
- Acadia Pharmaceuticals Inc$21
- AstraZeneca$20
- Abbott$19
- plus $87 from 6 others
What the payments were for
- Food & beverage$529100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 36 | $312 |
| Redhill Biopharma Inc. | 3 | $46 |
| Genentech USA, Inc. | 1 | $23 |
| Acadia Pharmaceuticals Inc | 1 | $21 |
| AstraZeneca | 1 | $20 |
| Abbott | 1 | $19 |
| Novartis | 1 | $18 |
| Pfizer | 1 | $16 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
| Novo Nordisk | 1 | $13 |
| GSK | 1 | $13 |
| Melinta Therapeutics, LLC | 1 | $13 |
How this compares
$529 in reported general payments places this provider in the 60th percentile of 1,071 internal medicine providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JanuviaSitagliptin Phosphate | 17 | $14,678 |
| Atorvastatin Calcium | 216 | $1,440 |
| Losartan Potassium | 147 | $994 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 29 | $592 |
| Pantoprazole Sodium | 39 | $463 |
| Omeprazole | 64 | $418 |
| Megestrol Acetate | 11 | $400 |
| Gabapentin | 33 | $400 |
| Levothyroxine Sodium | 66 | $372 |
| Alprazolam | 47 | $328 |
| Ibuprofen | 57 | $297 |
| Metformin Hcl | 104 | $289 |
| Pioglitazone Hcl | 43 | $285 |
| Hydroxyzine Hcl | 19 | $276 |
| Tamsulosin Hcl | 47 | $268 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in North Las Vegas
- J Cal NoordaNorth Las Vegas$15K
- Israel AlvaradoNorth Las Vegas$13K
- Darin BrimhallLas Vegas$39.7M
- Alton WaltersLas Vegas$8.9M
- Michael JacobsLas Vegas$8.1M
- Nirupa PaulrajLas Vegas$5.8M
- Atoya AdamsLas Vegas$5.4M
- Roger EstevezLas Vegas$3.7M
- Syed PervaizLas Vegas$3.1M
- Marigene Salazar SharmaHenderson$2.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.